2005
DOI: 10.1007/s00436-005-1475-7
|View full text |Cite
|
Sign up to set email alerts
|

The treatment of mice with Lactobacillus casei induces protection against Babesia microti infection

Abstract: In this study, we report that administration of Lactobacillus casei confers protection to mice against the intracellular protozoan Babesia microti. Mice treated with L. casei orally or intraperitoneally were inoculated 7 days later with an infectious dose of B. microti. Mice treated with lactobacilli showed significant reduction in the percentage of parasitized erythrocytes (PPE) compared to untreated mice. When mice were inoculated intraperitoneally with L. casei 3 or 0 days before challenge with B. microti, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
1

Year Published

2008
2008
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 25 publications
0
12
1
Order By: Relevance
“…It is important to note that bovines immunized with VAC-LC do not show the clinical signs observed in cattle inoculated with VAC after vaccination [19,20]; however, the underlying mechanism responsible for this protection is not known. The only evidence we have is the recorded level of total IgG anti-Babesia [21], which is higher in animals treated with VAC and L. casei than in bovines immunized with VAC [18,19]. To date, there are no published studies on the levels of IgG1 and IgG2 against Babesia in bovines immunized with VAC or VAC and L. casei.…”
Section: Introductioncontrasting
confidence: 46%
See 1 more Smart Citation
“…It is important to note that bovines immunized with VAC-LC do not show the clinical signs observed in cattle inoculated with VAC after vaccination [19,20]; however, the underlying mechanism responsible for this protection is not known. The only evidence we have is the recorded level of total IgG anti-Babesia [21], which is higher in animals treated with VAC and L. casei than in bovines immunized with VAC [18,19]. To date, there are no published studies on the levels of IgG1 and IgG2 against Babesia in bovines immunized with VAC or VAC and L. casei.…”
Section: Introductioncontrasting
confidence: 46%
“…On the other hand, the use of the immunostimulant lactic-acid bacteria Lactobacillus casei as an alternative control measure of distinct parasitic diseases has been proposed [17]. In this context, it was demonstrated that L. casei, by itself, induces protective responses against Babesia microti in mice when inoculated before or the same day of the challenge infection [18] and against B. bovis and B. bigemina in cattle when the lactic-acid bacteria is administered with VAC under laboratory controlled conditions [19] and in extreme natural field conditions [20]. It is important to note that bovines immunized with VAC-LC do not show the clinical signs observed in cattle inoculated with VAC after vaccination [19,20]; however, the underlying mechanism responsible for this protection is not known.…”
Section: Introductionmentioning
confidence: 99%
“…Oral or intraperitoneal treatments of L. casei ATCC 7469 in Babesia microti (Gray strain) infected mice significantly reduced parasitemia, potentially through a stimulation of the innate immune system [56]. The protective response was improved when the lactobacilli were administered 3 days before or on the same day of parasite infection versus 7 days before.…”
Section: Other Parasitesmentioning
confidence: 99%
“…It has been demonstrated that the administration of L. casei to mice also stimulates a protective immune response against a variety of parasites 4 . In recent studies it was demonstrated that mice treated with L. casei and then exposed to B. microti showed a significantly lower parasitemia compared to that observed in control mice, and, after which, the mice showed a solid immunity against reinfection 5 . It is also known that in bovines a protective immune response against B. bovis involves a Th1‐type response with the production of interferon gamma (IFN‐γ), interleukin 12 (IL‐12), nitric oxide, and immunoglobulin G2 6,7 .…”
Section: Introductionmentioning
confidence: 99%